Correction to: First Development, Optimization, and Stability Control of a Pediatric Oral Atenolol Formulation

被引：0
|
作者：
Mauro Morri
Patricia Castellano
Darío Leonardi
Silvana Vignaduzzo
机构：
[1] Universidad Nacional de Rosario,Planta piloto de Producción de Medicamentos, Facultad de Ciencias Bioquímicas y Farmacéuticas
[2] Universidad Nacional de Rosario,Área Análisis de Medicamentos, Departamento Química Orgánica, Facultad de Ciencias Bioquímicas y Farmacéuticas
[3] IQUIR-CONICET,Área Técnica Farmacéutica, Departamento Farmacia, Facultad de Ciencias Bioquímicas y Farmacéuticas
[4] Universidad Nacional de Rosario,Facultad de Ciencias Bioquímicas y Farmacéuticas
[5] Universidad Nacional de Rosario,undefined
来源：
AAPS PharmSciTech | 2018年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the INTRODUCTION section, Atenolol is defined in parenthesis as (ATN, Fig. 1.) The correct definition is (ATN). Fig 1 corresponds to the RESULTS section.
引用
收藏
页码：3907 / 3907
相关论文
共 50 条
  • [11] FORMULATION DEVELOPMENT AND OPTIMIZATION OF MEDICATED LOZENGES FOR PEDIATRIC USE
    Pattanayak, Dharmajit
    Das, Saumya
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (01): : 139 - 141
  • [12] Formulation and Stability Study of Omeprazole Oral Liquid Suspension for Pediatric Patients
    Boscolo, Oriana
    Perra, Francesco
    Salvo, Leandro
    Buontempo, Fabian
    Lucangioli, Silvia
    HOSPITAL PHARMACY, 2020, 55 (05) : 314 - 322
  • [13] Formulation development and evaluation of controlled porosity osmotic pump delivery system for oral delivery of atenolol
    Rathore, Garvendra S.
    Gupta, R. N.
    ASIAN JOURNAL OF PHARMACEUTICS, 2012, 6 (02) : 151 - 160
  • [14] Formulation Development and Optimization of Floating Microballoons for Oral Delivery of Domperidone
    Gorde, Nilesh K.
    Pawar, Harshal A.
    Khutle, Nilesh
    Chaudhari, Yogesh
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND PHYTOPHARMACOLOGICAL RESEARCH, 2012, 2 (02): : 101 - 108
  • [15] Development, evaluation, and influence of formulation and process variables on in vitro performance of oral elementary osmotic device of atenolol
    Arjun, N.
    Narendar, D.
    Sunitha, K.
    Harika, K.
    Nagaraj, B.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2016, 6 (04) : 238 - 246
  • [16] Palatability and Stability Studies to Optimize a Carvedilol Oral Liquid Formulation for Pediatric Use
    Chiclana-Rodriguez, Blanca
    Garcia-Montoya, Encarnacion
    Romero-Obon, Miquel
    Rouaz-El-Hajoui, Khadija
    Nardi-Ricart, Anna
    Sune-Pou, Marc
    Sune-Negre, Josep M.
    Perez-Lozano, Pilar
    PHARMACEUTICS, 2024, 16 (01)
  • [17] Development of a Rapidly Dissolvable Oral Pediatric Formulation for Mefloquine Using Liposomes
    Tang, Wei-Lun
    Tang, Wei-Hsin
    Chen, Weihsu Claire
    Diako, Charles
    Ross, Carolyn F.
    Li, Shyh-Dar
    MOLECULAR PHARMACEUTICS, 2017, 14 (06) : 1969 - 1979
  • [18] Formulation Optimization of Extemporaneous Oral Liquids Containing Naloxone and Propranolol for Pediatric Use
    Atteback, Maria
    Hedin, Bengt
    Mattsson, Sofia
    SCIENTIA PHARMACEUTICA, 2022, 90 (01)
  • [19] Development of an extemporaneous oral liquid formulation of oxandrolone and its stability evaluation
    Garg, Alka
    Garg, Sanjay
    She, Richard Wong
    BURNS, 2011, 37 (07) : 1150 - 1153
  • [20] Formulation, Development and Stability of Granisetron Sustained Release Oral Dispersible Tablets
    Krishna, C. P.
    Rangra, N. K.
    Samanta, R.
    Pradhan, K. K.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 80 (02) : 342 - 349
12345